Hanna M. Rajala

Helsinki, Finland

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 24 publications

Ruxolitinib treatment outcomes in acute graft-versus-host disease (aGvHD) in a real-world setting in Finland.

Ruxolitinib treatment outcomes in acute graft-versus-host disease (aGvHD) in a real-world setting in Finland.

Journal: Annals of hematology

Published: March 14, 2025

Somatic mutations associate with clonal expansion of CD8+ T cells.

Somatic mutations associate with clonal expansion of CD8+ T cells.

Journal: Science advances

Published: June 07, 2024

Anti-COX-2 autoantibody is a novel biomarker of immune aplastic anemia.

Anti-COX-2 autoantibody is a novel biomarker of immune aplastic anemia.

Journal: Leukemia

Published: May 13, 2022

Single-cell characterization of leukemic and non-leukemic immune repertoires in CD8+ T-cell large granular lymphocytic leukemia.

Single-cell characterization of leukemic and non-leukemic immune repertoires in CD8+ T-cell large granular lymphocytic leukemia.

Journal: Nature communications

Published: June 14, 2021

STAT3 activation in large granular lymphocyte leukemia is associated with cytokine signaling and DNA hypermethylation.

STAT3 activation in large granular lymphocyte leukemia is associated with cytokine signaling and DNA hypermethylation.

Journal: Leukemia

Published: February 12, 2021

Gemtuzumab-Ozogamicin-Related Impaired Hemoglobin-Haptoglobin Scavenging as On-Target/Off-Tumor Toxicity of Anti-CD33 AML Therapy: A Report of Two Cases.

Gemtuzumab-Ozogamicin-Related Impaired Hemoglobin-Haptoglobin Scavenging as On-Target/Off-Tumor Toxicity of Anti-CD33 AML Therapy: A Report of Two Cases.

Journal: Case reports in hematology

Published: October 06, 2020

Somatic mutations in lymphocytes in patients with immune-mediated aplastic anemia.

Somatic mutations in lymphocytes in patients with immune-mediated aplastic anemia.

Journal: Leukemia

Published: September 04, 2020

Dominant TOM1 mutation associated with combined immunodeficiency and autoimmune disease.

Dominant TOM1 mutation associated with combined immunodeficiency and autoimmune disease.

Journal: NPJ genomic medicine

Published: November 07, 2018

Tyrosine kinase inhibitor therapy-induced changes in humoral immunity in patients with chronic myeloid leukemia.

Tyrosine kinase inhibitor therapy-induced changes in humoral immunity in patients with chronic myeloid leukemia.

Journal: Journal of cancer research and clinical oncology

Published: February 13, 2017

Drug sensitivity profiling identifies potential therapies for lymphoproliferative disorders with overactive JAK/STAT3 signaling.

Drug sensitivity profiling identifies potential therapies for lymphoproliferative disorders with overactive JAK/STAT3 signaling.

Journal: Oncotarget

Published: December 21, 2016

A novel class of somatic mutations in blood detected preferentially in CD8+ cells.

A novel class of somatic mutations in blood detected preferentially in CD8+ cells.

Journal: Clinical immunology (Orlando, Fla.)

Published: October 06, 2016

LGL leukemia and autoimmunity - the borderline between autoimmune disease and cancer is becoming blurred.

LGL leukemia and autoimmunity - the borderline between autoimmune disease and cancer is becoming blurred.

Journal: Duodecim; laaketieteellinen aikakauskirja

Published: January 01, 2016

Showing 1-12 of 24

Last Updated: 09/26/2026